0001193125-15-218624.txt : 20150610 0001193125-15-218624.hdr.sgml : 20150610 20150610060759 ACCESSION NUMBER: 0001193125-15-218624 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20150610 DATE AS OF CHANGE: 20150610 GROUP MEMBERS: ADAM GRAY GROUP MEMBERS: CHRISTOPHER SHACKELTON GROUP MEMBERS: COLISEUM CAPITAL PARTNERS II, L.P. GROUP MEMBERS: COLISEUM CAPITAL PARTNERS, L.P. GROUP MEMBERS: COLISEUM CAPITAL, LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LHC Group, Inc CENTRAL INDEX KEY: 0001303313 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 710918189 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81518 FILM NUMBER: 15922232 BUSINESS ADDRESS: STREET 1: 420 WEST PINHOOK ROAD CITY: LAFAYETTE STATE: LA ZIP: 70503 BUSINESS PHONE: 337-233-1307 MAIL ADDRESS: STREET 1: 420 WEST PINHOOK ROAD CITY: LAFAYETTE STATE: LA ZIP: 70503 FORMER COMPANY: FORMER CONFORMED NAME: LHC Group, LLC DATE OF NAME CHANGE: 20040915 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Coliseum Capital Management, LLC CENTRAL INDEX KEY: 0001409751 IRS NUMBER: 223918079 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: METRO CENTER STREET 2: 1 STATION PLACE, 7TH FLOOR SOUTH CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-883-0100 MAIL ADDRESS: STREET 1: METRO CENTER STREET 2: 1 STATION PLACE, 7TH FLOOR SOUTH CITY: STAMFORD STATE: CT ZIP: 06902 SC 13D/A 1 d940778dsc13da.htm SC 13D/A SC 13D/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934

(Amendment No. 4)*

 

 

LHC GROUP, INC.

(Name of Issuer)

Common Stock, Par Value $0.01 Per Share

(Title of Class of Securities)

50187A107

(CUSIP Number)

Christopher Shackelton/Adam Gray

Metro Center

1 Station Place, 7th Floor South

Stamford, CT 06902

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

June 5, 2015

(Date of Event Which Requires Filing of this Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of sections 240.13d-1(e), 240.13d-1(f) or 140.13d-1(g), check the following box.   ¨

 

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

Page 1 of 11


CUSIP No. 50187A107 (Common Stock)

 

  1. 

Names of Reporting Persons

 

Coliseum Capital Management, LLC

  2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        (b)  x

 

  3.

SEC Use Only

 

  4.

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

  5. 

Sole Voting Power

 

0

  6.

Shared Voting Power

 

2,165,471

  7.

Sole Dispositive Power

 

0

  8.

Shared Dispositive Power

 

2,165,471

  9. 

Aggregate Amount Beneficially Owned by Each Reporting Person

 

2,165,471

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨

 

11.

Percent of Class Represented by Amount in Row (9)

 

12.05%

12.

Type of Reporting Person (See Instructions)

 

OO, IA

 

 

Page 2 of 11


CUSIP No. 50187A107 (Common Stock)

 

  1. 

Names of Reporting Persons

 

Coliseum Capital, LLC

  2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        (b)  x

 

  3.

SEC Use Only

 

  4.

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

  5. 

Sole Voting Power

 

0

  6.

Shared Voting Power

 

1,514,569

  7.

Sole Dispositive Power

 

0

  8.

Shared Dispositive Power

 

1,514,569

  9. 

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,514,569

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨

 

11.

Percent of Class Represented by Amount in Row (9)

 

8.40%

12.

Type of Reporting Person (See Instructions)

 

OO

 

 

Page 3 of 11


CUSIP No. 50187A107 (Common Stock)

 

  1. 

Names of Reporting Persons

 

Coliseum Capital Partners, L.P.

  2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        (b)  x

 

  3.

SEC Use Only

 

  4.

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

  5. 

Sole Voting Power

 

0

  6.

Shared Voting Power

 

1,161,271

  7.

Sole Dispositive Power

 

0

  8.

Shared Dispositive Power

 

1,161,271

  9. 

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,161,271

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨

 

11.

Percent of Class Represented by Amount in Row (9)

 

6.46%

12.

Type of Reporting Person (See Instructions)

 

PN

 

 

Page 4 of 11


CUSIP No. 50187A107 (Common Stock)

 

  1. 

Names of Reporting Persons

 

Coliseum Capital Partners II, L.P.

  2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        (b)  x

 

  3.

SEC Use Only

 

  4.

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

  5. 

Sole Voting Power

 

0

  6.

Shared Voting Power

 

353,298

  7.

Sole Dispositive Power

 

0

  8.

Shared Dispositive Power

 

353,298

  9. 

Aggregate Amount Beneficially Owned by Each Reporting Person

 

353,298

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨

 

11.

Percent of Class Represented by Amount in Row (9)

 

1.97%

12.

Type of Reporting Person (See Instructions)

 

PN

 

 

Page 5 of 11


CUSIP No. 50187A107 (Common Stock)

 

  1. 

Names of Reporting Persons

 

Adam Gray

  2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        (b)  x

 

  3.

SEC Use Only

 

  4.

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

  5. 

Sole Voting Power

 

0

  6.

Shared Voting Power

 

2,165,471

  7.

Sole Dispositive Power

 

0

  8.

Shared Dispositive Power

 

2,165,471

  9. 

Aggregate Amount Beneficially Owned by Each Reporting Person

 

2,165,471

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨

 

11.

Percent of Class Represented by Amount in Row (9)

 

12.05%

12.

Type of Reporting Person (See Instructions)

 

IN

 

 

Page 6 of 11


CUSIP No. 50187A107 (Common Stock)

 

  1. 

Names of Reporting Persons

 

Christopher Shackelton

  2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        (b)  x

 

  3.

SEC Use Only

 

  4.

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

  5. 

Sole Voting Power

 

0

  6.

Shared Voting Power

 

2,165,471

  7.

Sole Dispositive Power

 

0

  8.

Shared Dispositive Power

 

2,165,471

  9. 

Aggregate Amount Beneficially Owned by Each Reporting Person

 

2,165,471

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨

 

11.

Percent of Class Represented by Amount in Row (9)

 

12.05%

12.

Type of Reporting Person (See Instructions)

 

IN

 

 

Page 7 of 11


CUSIP No. 50187A107 (Common Stock)

 

Explanatory Note: This Amendment No. 4 (this “Amendment”), to the Schedule 13D (the “Initial 13D”) filed by the Filers (as defined below in Item 2) with the U.S. Securities and Exchange Commission (the “Commission”) on November 16, 2012, as amended and supplemented by Amendment No. 1 to the Initial 13D filed on March 14, 2013, Amendment No. 2 to the Initial 13D filed on September 17, 2013 and Amendment No. 3 to the Initial 13D filed on August 21, 2014, amends and supplements the items set forth herein.

Item 1. Security and Issuer.

Item 1 is amended and restated in its entirety as follows.

The title of the class of equity securities to which this statement relates to is the Common Stock, $0.01 par value per share (the “Common Stock”) of LHC Group, Inc., a Delaware corporation (the “Issuer”). The principal executive offices of the Issuer are located at 420 West Pinhook Road, Suite A, Lafayette, Louisiana 70503.

Item 2. Identity and Background.

Item 2 is amended and restated in its entirety as follows.

 

  (a) As used in this statement, the term “Filers” collectively refers to:

 

    Coliseum Capital Management, LLC, a Delaware limited liability company (“CCM”);

 

    Coliseum Capital, LLC, a Delaware limited liability company (“CC”);

 

    Coliseum Capital Partners, L.P., a Delaware limited partnership (“CCP”);

 

    Coliseum Capital Partners II, L.P., a Delaware limited partnership (“CCP2”);

 

    Adam Gray (“Gray”); and

 

    Christopher Shackelton (“Shackelton”).

 

  (b) The business address of the Filers is Metro Center, 1 Station Place, 7th Floor South, Stamford, CT 06902.

 

  (c) Present principal occupation or employment of the Filers and the name, principal business and address of any corporation or other organization in which such employment is conducted:

CCM is the investment adviser to CCP and CCP2, which are investment limited partnerships. CC is the General Partner of CCP and CCP2. Gray and Shackelton are the managers of CC and CCM. CCM is the manager with respect to the Common Stock.

 

  (d) During the last five years, none of the Filers has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

 

  (e) During the last five years, none of the Filers was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

 

Page 8 of 11


CUSIP No. 50187A107 (Common Stock)

 

 

  (f) The citizenship or place of organization for each of the Filers is listed in Row 6 of the cover pages hereto.

Item 5. Interest in Securities of the Issuer.

Item 5 is amended and supplemented as follows:

The information relating to the beneficial ownership of Common Stock by each of the Filers set forth in Rows 7 through 13 of the cover pages hereto is incorporated herein by reference. The percentages set forth in Row 13 for all cover pages filed herewith are calculated based upon 17,968,180 shares of Common Stock outstanding as of May 4, 2015, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2015, filed on May 7, 2015.

The Filers effected the following transactions in the Common Stock in open market transactions on the dates indicated, and such transactions are the only transactions in the Common Stock by the Filers in the sixty days preceding the filing of this Schedule 13D:

 

Name

   Purchase or Sale    Date      Number of
Shares
     Weighted
Average Price
Per Share
 

CCP

   Sale      6/3/2015         15,760       $ 36.27   

CCP2

   Sale      6/3/2015         3,988       $ 36.27   

Separate Account

   Sale      6/3/2015         6,286       $ 36.27   

CCP

   Sale      6/4/2015         11,512       $ 36.31   

CCP2

   Sale      6/4/2015         2,916       $ 36.31   

Separate Account

   Sale      6/4/2015         4,601       $ 36.31   

CCP

   Sale      6/5/2015         26,276       $ 36.30   

CCP2

   Sale      6/5/2015         6,656       $ 36.30   

Separate Account

   Sale      6/5/2015         10,499       $ 36.30   

CCP

   Sale      6/8/2015         4,759       $ 36.34   

CCP2

   Sale      6/8/2015         1,205       $ 36.34   

Separate Account

   Sale      6/8/2015         1,900       $ 36.34   

CCP

   Sale      6/9/2015         4,685       $ 36.39   

CCP2

   Sale      6/9/2015         1,187       $ 36.39   

Separate Account

   Sale      6/9/2015         1,870       $ 36.39   

 

Page 9 of 11


CUSIP No. 50187A107 (Common Stock)

 

The information in Item 6 is incorporated herein by reference.

Item 6. Contracts, Arrangement, Understandings or Relationships with Respect to Securities of the Issuer.

CCM is an investment adviser whose clients, including CCP, CCP2 and the Separate Account, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock. CC is the general partner of CCP and CCP2. Gray and Shackelton are the managers of CC and CCM. CCM has the right to receive performance-related fees from the Separate Account and CC has the right to receive performance-related fees from CCP and CCP2.

Item 7. Material to Be Filed as Exhibits

 

Exhibit No.

  

Description of Exhibit

1    Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G
2    Power of Attorney of Christopher Shackelton
3    Power of Attorney of Adam Gray

 

Page 10 of 11


CUSIP No. 50187A107 (Common Stock)

 

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: June 9, 2015

 

COLISEUM CAPITAL MANAGEMENT, LLC COLISEUM CAPITAL, LLC
By:

/s/ Christopher Shackelton

By:

/s/ Christopher Shackelton

      Christopher Shackelton, Manager       Christopher Shackelton, Manager
COLISEUM CAPITAL PARTNERS, L.P. COLISEUM CAPITAL PARTNERS II, L.P.
By: Coliseum Capital, LLC, General Partner By: Coliseum Capital, LLC, General Partner
By:

/s/ Christopher Shackelton

By:

/s/ Christopher Shackelton

      Christopher Shackelton, Manager       Christopher Shackelton, Manager
CHRISTOPHER SHACKELTON ADAM GRAY
By: Christopher Shackelton

/s/ Christopher Shackelton

By:

/s/ Christopher Shackelton

Christopher Shackelton       Christopher Shackelton, Attorney-in-fact

 

Page 11 of 11

EX-99.1 2 d940778dex991.htm EX-99.1 EX-99.1

Exhibit 1

Joint Filing Agreement Pursuant to Rule 13d-1

This agreement is made pursuant to Rule 13d-l(k)(1) under the Securities and Exchange Act of 1934, as amended (the “Act”) by and among the parties listed below, each referenced to herein as a “Joint Filer.” The Joint Filers agree that a statement of beneficial ownership as required by Sections 13(g) or 13(d) of the Act and the Rules thereunder may be filed on each of their behalf on Schedule 13G or Schedule 13D, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers state that they each satisfy the requirements for making a joint filing under Rule 13d-1.

Date: June 9, 2015

 

COLISEUM CAPITAL MANAGEMENT, LLC COLISEUM CAPITAL, LLC
By:

/s/ Christopher Shackelton

By:

/s/ Christopher Shackelton

      Christopher Shackelton, Manager       Christopher Shackelton, Manager
COLISEUM CAPITAL PARTNERS, L.P. COLISEUM CAPITAL PARTNERS II, L.P.
By: Coliseum Capital, LLC, General Partner By: Coliseum Capital, LLC, General Partner
By:

/s/ Christopher Shackelton

By:

/s/ Christopher Shackelton

      Christopher Shackelton, Manager       Christopher Shackelton, Manager
CHRISTOPHER SHACKELTON ADAM GRAY
By: Christopher Shackelton

/s/ Christopher Shackelton

By:

/s/ Christopher Shackelton

Christopher Shackelton       Christopher Shackelton, Attorney-in-fact
EX-99.2 3 d940778dex992.htm EX-99.2 EX-99.2

Exhibit 2

POWER OF ATTORNEY

June 9, 2015

Know all by these presents, that the undersigned hereby constitutes and appoints Adam Gray the undersigned’s true and lawful attorney-in-fact to:

1. execute for and on behalf of the undersigned, in the undersigned’s capacity as a beneficial owner and a director of LHCG Group, Inc. (the “Company”), (a) Schedules 13D and 13G (and any amendments thereto) in accordance with Sections 13(d) and 13(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) and the rules thereunder, (b) Forms 3, 4, and 5 (and any amendments thereto) in accordance with Section 16(a) of the Exchange Act and the rules thereunder, and (c) any other forms or reports the undersigned may be required to file in connection with the undersigned’s ownership, acquisition, or disposition of securities of the Company;

2. do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Schedule 13D, Schedule 13G, Form 3, 4, or 5, or other form or report (or any amendment thereto), and timely file such schedule, form or report with the U.S. Securities and Exchange Commission and any stock exchange or similar authority; and

3. take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 13 and Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Schedules 13D and 13G and Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.


IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date first written above.

 

/s/ Christopher Shackelton

Signature

Christopher Shackelton

Print Name
EX-99.3 4 d940778dex993.htm EX-99.3 EX-99.3

Exhibit 3

POWER OF ATTORNEY

June 9, 2015

Know all by these presents, that the undersigned hereby constitutes and appoints Christopher Shackelton the undersigned’s true and lawful attorney-in-fact to:

1. execute for and on behalf of the undersigned, in the undersigned’s capacity as a beneficial owner and possibly a director by deputization, as applicable, of LHCG Group, Inc. (the “Company”), (a) Schedules 13D and 13G (and any amendments thereto) in accordance with Sections 13(d) and 13(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) and the rules thereunder, (b) Forms 3, 4, and 5 (and any amendments thereto) in accordance with Section 16(a) of the Exchange Act and the rules thereunder, and (c) any other forms or reports the undersigned may be required to file in connection with the undersigned’s ownership, acquisition, or disposition of securities of the Company;

2. do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Schedule 13D, Schedule 13G, Form 3, 4, or 5, or other form or report (or any amendment thereto), and timely file such schedule, form or report with the U.S. Securities and Exchange Commission and any stock exchange or similar authority; and

3. take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 13 and Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Schedules 13D and 13G and Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.


IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date first written above.

 

/s/ Adam Gray

Signature

Adam Gray

Print Name